Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,519,768
  • Shares Outstanding, K 1,245,077
  • Annual Sales, $ 27,116 M
  • Annual Income, $ 5,665 M
  • 60-Month Beta 0.19
  • Price/Sales 3.08
  • Price/Cash Flow 7.48
  • Price/Book 3.67
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 26.71% ( +1.44%)
  • Historical Volatility 15.57%
  • IV Percentile 91%
  • IV Rank 76.95%
  • IV High 29.79% on 10/27/23
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 1.38
  • Today's Volume 106,787
  • Volume Avg (30-Day) 16,141
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 245,431
  • Open Int (30-Day) 234,387

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.23
  • Number of Estimates 12
  • High Estimate 1.80
  • Low Estimate -1.74
  • Prior Year 1.37
  • Growth Rate Est. (year over year) -116.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.09 +0.28%
on 04/25/24
73.87 -11.64%
on 03/28/24
-7.31 (-10.07%)
since 03/25/24
3-Month
65.09 +0.28%
on 04/25/24
80.51 -18.93%
on 01/26/24
-14.96 (-18.65%)
since 01/25/24
52-Week
65.09 +0.28%
on 04/25/24
87.86 -25.72%
on 01/19/24
-20.32 (-23.74%)
since 04/25/23

Most Recent Stories

More News
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript

GILD earnings call for the period ending March 31, 2024.

GILD : 65.27 (-2.70%)
Gilead: Q1 Earnings Snapshot

Gilead: Q1 Earnings Snapshot

GILD : 65.27 (-2.70%)
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,124.00 (+0.82%)
NQM24 : 17,766.00 (+1.13%)
META : 441.38 (-10.56%)
TSLA : 170.18 (+4.97%)
HAS : 64.97 (-0.09%)
TXN : 175.25 (+0.25%)
ODFL : 196.66 (+0.82%)
MSFT : 399.04 (-2.45%)
GOOGL : 156.00 (-1.97%)
MRK : 130.72 (+2.93%)
GILD : 65.27 (-2.70%)
CAT : 338.00 (-7.02%)
Better Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

LLY : 724.87 (-1.00%)
PFE : 25.26 (-3.84%)
BMY : 44.70 (-8.51%)
NVO : 125.79 (-0.29%)
GILD : 65.27 (-2.70%)
MRK : 130.72 (+2.93%)
VUG : 329.19 (-0.57%)
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Dividend stocks can be a smart way to ride out market volatility.

COMP : 3.22 (-3.30%)
NVDA : 826.32 (+3.71%)
WBA : 17.60 (-1.18%)
GILD : 65.27 (-2.70%)
KHC : 38.37 (-0.52%)
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases

USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases, which would represent a record high. Among 10 of the most common...

ONCY : 1.0800 (+1.89%)
ONC.TO : 1.49 (+1.36%)
GILD : 65.27 (-2.70%)
GTHX : 3.86 (-3.26%)
AZN : 75.03 (+5.38%)
HOLX : 75.71 (-1.30%)
Biotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

ONCY : 1.0800 (+1.89%)
ONC.TO : 1.49 (+1.36%)
GILD : 65.27 (-2.70%)
GTHX : 3.86 (-3.26%)
AZN : 75.03 (+5.38%)
HOLX : 75.71 (-1.30%)
3 No-Brainer Dividend Stocks to Buy in April

Income investors will find a lot to like about these stocks.

ABBV : 167.29 (-0.30%)
GILD : 65.27 (-2.70%)
PFE : 25.26 (-3.84%)
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows

All of these stocks pay generous dividends that income investors will appreciate.

SBUX : 87.84 (-1.03%)
BCE : 32.89 (-0.51%)
GILD : 65.27 (-2.70%)
Minister of Justice and Attorney General of Canada announces judicial appointments in the province of Ontario

/CNW/ - The Honourable Arif Virani, Minister of Justice and Attorney General of Canada, today announced the following appointments under the judicial...

GILD : 65.27 (-2.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 69.89
2nd Resistance Point 68.90
1st Resistance Point 67.08
Last Price 65.27
1st Support Level 64.27
2nd Support Level 63.28
3rd Support Level 61.46

See More

52-Week High 87.86
Fibonacci 61.8% 79.16
Fibonacci 50% 76.48
Fibonacci 38.2% 73.79
Last Price 65.27
52-Week Low 65.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar